MedPath

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

Not Applicable
Completed
Conditions
Speech
Interventions
Device: TMS
Behavioral: somatosensory acuity measurement
Registration Number
NCT05723575
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds, which may be applied to people who have communication disorders. 15 participants will be enrolled into this part of the study and can expect to be on study for 4 visits of 2-4 hours each.

Detailed Description

The overall study (Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation) aims to understand how cognitive, perceptual, and motor processes are integrated in the control of speech movements. The investigators study how this complex skill is performed in healthy speakers to understand how this system functions, how this skill relates to the perception of speech, and what role different parts of the brain play in this process. Different studies look at how speech motor control is executed, maintained, and changed. Overall, the study will recruit 329 participants over the course of 5 years. Participants can expect to be on study for up to 3 weeks.

The entire study is composed of 8 experiments and 6 interventions. The present record represents the experiments involving transcranial magnetic stimulation (TMS), i.e. Experiment 7: Using TMS to alter somatosensory acuity.

This paradigm uses theta-burst transcranial magnetic stimulation (tbTMS) to modulate the excitability of sensory cortices to examine the effect on sensory acuity and sensorimotor adaptation. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation.

The effect of the stimulation on auditory acuity will be measured through a tactile discrimination task in which participants report the relative amplitude and/or timing of vibrating probes pressed lightly into the tongue using a custom device (a version of the Corticalmetrics Brain Gauge adapted to study the orofacial system).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria
  • Native language other than English

  • Any neurological disorders other than the disorder of interest

  • Any history of hearing disorders

  • Uncorrected vision problems that prevent participants from seeing visually-presented stimuli

  • Significant cognitive impairments that prevent participants from carrying out the task or from giving informed consent

  • Vulnerable populations (minors and prisoners)

  • Additional exclusionary criteria for TMS:

    • Implanted paramagnetic materials (metal clips, plates, pacemakers, etc.)
    • Increased risk in the event of a seizure
    • Serious heart disease
    • Increased intracranial pressure
    • Pregnancy
    • History of seizures
    • Family history of epilepsy
    • Epileptogenic medications
    • Chronic or transient disruption of sleep (including jet lag)
    • History of fainting
    • Chronic or transient increase in stressful experiences
    • Use of illegal drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy Adult Speakerssomatosensory acuity measurementhealthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+
Healthy Adult SpeakersTMShealthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+
Primary Outcome Measures
NameTimeMethod
Somatosensory Acuity: Spatial Amplitude Discrimination Threshold (SDT)up to 1 hour

The investigators will measure thresholds in spatial amplitude discrimination (SDT). These thresholds represent the smallest difference that participants can detect in the amplitude of vibration on the tongue. Vibratory stimulation is delivered by the corticalmetrics Brain Gauge device, which has two probes, one on the left and one on the right side of the tongue. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation.

Tactile acuity measured in this way is used as a proxy for full somatosensation, given the difficulty in measuring proprioception in the oral system. Tactile acuity has been suggested to be important for speech production, as tactile contact is maintained parasagittally during vowel production and tactile deprivation leads to imprecise speech movements.

Somatosensory Acuity: Temporal Discrimination Threshold (TDT)up to 1 hour

The investigators will measure thresholds in temporal discrimination (SDT). These thresholds represent the smallest difference that participants can detect in the timing of vibrations on the tongue. Vibratory stimulation is delivered by the corticalmetrics Brain Gauge device, which has two probes, one on the left and one on the right side of the tongue. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation.

Tactile acuity measured in this way is used as a proxy for full somatosensation, given the difficulty in measuring proprioception in the oral system. Tactile acuity has been suggested to be important for speech production, as tactile contact is maintained parasagittally during vowel production and tactile deprivation leads to imprecise speech movements.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath